Skip to main content

The European Journal of Health Economics

Ausgabe 8/2022

Inhalt (13 Artikel)

Value drivers of development stage biopharma companies

  • Open Access
  • Original Paper

Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev, Thomas Michaeli

Do we care about high-cost patients? Estimating the savings on health spending by integrated care

  • Original Paper

Karen Geurts, Marc Bruijnzeels, Erik Schokkaert

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

  • Open Access
  • Original Paper

Don Husereau, Michael Drummond, Federico Augustovski, Esther de Bekker-Grob, Andrew H. Briggs, Chris Carswell, Lisa Caulley, Nathorn Chaiyakunapruk, Dan Greenberg, Elizabeth Loder, Josephine Mauskopf, C. Daniel Mullins, Stavros Petrou, Raoh-Fang Pwu, Sophie Staniszewska, Ivett Jakab, Emma Kinloch, Eric Low, Jean Mossman, Declan Noone, Phil Posner, Jo Watson, Wendy Babidge, Lyn Beamesderfer, Dior Beerens, Chris Carswell, Tillie Cryer, Ana Donnelly, Manuel Espinoza, Dan Greenberg, Wolfgang Greiner, Laura Happe, Mickaël Hiligsmann, Christine Laine, Lin Lee, Ken Lee, Elizabeth Loder, Natalie Pafitis, Julia Robinson, Kenneth Stein, Eva Szunyogova, Wim Weber, Timothy Wrightson, Brian Zikmund-Fisher, Marie-Claude Aubin, Marc Berger, John Campbell, Doug Coyle, Matthew Dyer, Richard Edlin, Rita Faria, Veronica Gallegos, Alastair Gray, Scott Grosse, Jason Guertin, Dyfrig Hughes, Florencia Hutter, Denny John, Hanin Farhana Kamaruzaman, David Kim, Murray Krahn, Dan Moldaver, Ku Rahim Ku AbdNurhasni, Daniela Vianna Pachito, Michael Paulden, Clinton Pecenka, Andrés Pichon-Riviere, John Powell, Lisa Prosser, Dean Regier, Anna Ringborg, Rossana Rivas, Chris Sampson, Marisa Santos, Paul Scuffham, Mark Sculpher, Katia Senna, Eldon Spackman, Lotte Steuten, David Tamblyn, Kilgore Trout, Dick Willke, Torbjorn Wisloff, Tadesse Abegaz, Alex Kostyuk, Kelly Lenahan, Nan Luo, Joshua Soboil, Richard White, David Moher, Elizabeth Molsen

Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above

  • Open Access
  • Original Paper

Zsombor Zrubka, Péter Vékás, Péter Németh, Ágota Dobos, Ottó Hajdu, Levente Kovács, László Gulácsi, Judith Hibbard, Márta Péntek

Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data

  • Open Access
  • Original Paper

Aileen R. Neilson, Gareth T. Jones, Gary J. Macfarlane, Ejaz MI Pathan, Paul McNamee

Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective

  • Open Access
  • Original Paper

Daniela Zinzi, Ioanna Vlachaki, Edel Falla, Theo Mantopoulos, Dilip Nathwani

Does voluntary health insurance improve health and longevity? Evidence from European OECD countries

  • Original Paper

Simona Laura Dragos, Codruta Mare, Cristian Mihai Dragos, Gabriela Mihaela Muresan, Alexandra-Anca Purcel

Correction: Lifetime direct healthcare costs of treating colorectal cancer: a systematic review

  • Correction

Nazim Bhimani, Geoffrey Y. M. Wong, Charles Molloy, Mbathio Dieng, Patrick J. Kelly, Thomas J. Hugh